IL324481A - תכשירים והכנה של שלפוחית חוץ תאית - Google Patents
תכשירים והכנה של שלפוחית חוץ תאיתInfo
- Publication number
- IL324481A IL324481A IL324481A IL32448125A IL324481A IL 324481 A IL324481 A IL 324481A IL 324481 A IL324481 A IL 324481A IL 32448125 A IL32448125 A IL 32448125A IL 324481 A IL324481 A IL 324481A
- Authority
- IL
- Israel
- Prior art keywords
- ref
- composition
- extracellular vesicles
- milk
- tryptophan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1276—Globules of milk; Constituents thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363465073P | 2023-05-09 | 2023-05-09 | |
| US202463624637P | 2024-01-24 | 2024-01-24 | |
| US202463640825P | 2024-04-30 | 2024-04-30 | |
| PCT/US2024/028635 WO2024233809A2 (en) | 2023-05-09 | 2024-05-09 | Extracellular vesicle compositions and preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324481A true IL324481A (he) | 2026-01-01 |
Family
ID=93431226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324481A IL324481A (he) | 2023-05-09 | 2024-05-09 | תכשירים והכנה של שלפוחית חוץ תאית |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4709357A2 (he) |
| KR (1) | KR20260003368A (he) |
| CN (1) | CN121335693A (he) |
| AU (1) | AU2024269259A1 (he) |
| IL (1) | IL324481A (he) |
| WO (1) | WO2024233809A2 (he) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022170176A1 (en) * | 2021-02-05 | 2022-08-11 | The Trustees Of Columbia University In The City Of New York | Enhanced delivery vehicle for a treating agent |
| JP2024528708A (ja) * | 2021-07-21 | 2024-07-30 | パーデュー リサーチ ファウンデーション | がん免疫療法を増強するための免疫原性細胞死誘導剤のナノ構築物及びナノ粒子媒介性送達 |
-
2024
- 2024-05-09 IL IL324481A patent/IL324481A/he unknown
- 2024-05-09 WO PCT/US2024/028635 patent/WO2024233809A2/en not_active Ceased
- 2024-05-09 CN CN202480038896.4A patent/CN121335693A/zh active Pending
- 2024-05-09 EP EP24804284.8A patent/EP4709357A2/en active Pending
- 2024-05-09 AU AU2024269259A patent/AU2024269259A1/en active Pending
- 2024-05-09 KR KR1020257041081A patent/KR20260003368A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024269259A1 (en) | 2025-12-04 |
| CN121335693A (zh) | 2026-01-13 |
| WO2024233809A3 (en) | 2025-03-27 |
| WO2024233809A2 (en) | 2024-11-14 |
| EP4709357A2 (en) | 2026-03-18 |
| KR20260003368A (ko) | 2026-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260014085A1 (en) | Milk derived exosomes and uses thereof | |
| EP2628484B9 (en) | Platelet-rich plasma compositions | |
| AU2011331901B2 (en) | Anti-inflammatory compositions | |
| US20230313191A1 (en) | Rna comprising secretomes and methods of their use | |
| US11603394B2 (en) | Targeted effector proteins and uses thereof | |
| RS62244B1 (sr) | Tatk-cdkl5 fuzioni proteini, sastavi, formulacije i njihova upotreba | |
| KR102415978B1 (ko) | 레반-단백질 나노복합체 및 이의 용도 | |
| US20240226809A9 (en) | Methods of isolating exosomes | |
| KR100939983B1 (ko) | 히아루론산-소수성 폴리 아미노산 공중합체 | |
| WO2024233809A2 (en) | Extracellular vesicle compositions and preparation | |
| HK40130277A (zh) | 细胞外囊泡组合物和制备 | |
| JP6247687B2 (ja) | 疎水性タンパク質の新規放出システム | |
| JPWO2010058517A1 (ja) | IgGおよび/またはIgGのFc断片を含む神経細胞刺激剤 | |
| HK40103176A (zh) | 分离外泌体的方法 | |
| KR20250144089A (ko) | 밀크 엑소좀을 유효성분으로 포함하는 키 성장 촉진용 조성물 | |
| EP1581623A2 (en) | Trefoil domain-containing polypeptides and uses thereof | |
| EP4714496A2 (en) | Treatment of neuronal ceroid lipofuscinosis | |
| EP4622653A1 (en) | Compositions based on a mixture of bioactive molecules and exosomes for use in the treatment of conditions requiring tissue repair and regeneration | |
| JP2017530189A (ja) | 低分子量ペプチド又はタンパク質のナノ沈殿物を調製する方法 | |
| KR20170041116A (ko) | 신경계의 보호 및/또는 복구용 조성물 및 방법 |